Impact of choice of inhalers for asthma care on global carbon footprint and societal costs: a long-term economic evaluation Article Swipe
Kalé Kponee-Shovein
,
Jessica Marvel
,
Ryotaro Ishikawa
,
Abhay Choubey
,
Harneet Kaur
,
Khadidja Ngom
,
Iman Fakih
,
Natalia Swartz
,
Todd Schatzki
,
James Signorovitch
·
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1080/13696998.2022.2088196
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1080/13696998.2022.2088196
Global efforts by environmental and health-policy decision-makers to substitute currently available MDIs with DPIs for asthma control would result in substantial reductions in GHG emissions with manageable costs, or potential cost savings, depending on the SCC. Policies that decrease use of MDIs warrant global attention.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1080/13696998.2022.2088196
- OA Status
- diamond
- Cited By
- 27
- References
- 29
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4282046044
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4282046044Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1080/13696998.2022.2088196Digital Object Identifier
- Title
-
Impact of choice of inhalers for asthma care on global carbon footprint and societal costs: a long-term economic evaluationWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-06-10Full publication date if available
- Authors
-
Kalé Kponee-Shovein, Jessica Marvel, Ryotaro Ishikawa, Abhay Choubey, Harneet Kaur, Khadidja Ngom, Iman Fakih, Natalia Swartz, Todd Schatzki, James SignorovitchList of authors in order
- Landing page
-
https://doi.org/10.1080/13696998.2022.2088196Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1080/13696998.2022.2088196Direct OA link when available
- Concepts
-
Medicine, Inhaler, Carbon footprint, Asthma, Greenhouse gas, Per capita, Environmental health, Population, Environmental science, Ecology, Internal medicine, BiologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
27Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 12, 2024: 12, 2023: 3Per-year citation counts (last 5 years)
- References (count)
-
29Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4282046044 |
|---|---|
| doi | https://doi.org/10.1080/13696998.2022.2088196 |
| ids.doi | https://doi.org/10.1080/13696998.2022.2088196 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/35686860 |
| ids.openalex | https://openalex.org/W4282046044 |
| fwci | 5.53225929 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000280 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Administration, Inhalation |
| mesh[1].qualifier_ui | Q000188 |
| mesh[1].descriptor_ui | D001249 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | drug therapy |
| mesh[1].descriptor_name | Asthma |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D058572 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Carbon Footprint |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D003362 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Cost-Benefit Analysis |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D006801 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Humans |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D036501 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Metered Dose Inhalers |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D009330 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Nebulizers and Vaporizers |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D000280 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Administration, Inhalation |
| mesh[8].qualifier_ui | Q000188 |
| mesh[8].descriptor_ui | D001249 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | drug therapy |
| mesh[8].descriptor_name | Asthma |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D058572 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Carbon Footprint |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D003362 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Cost-Benefit Analysis |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D006801 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Humans |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D036501 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Metered Dose Inhalers |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D009330 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Nebulizers and Vaporizers |
| type | article |
| title | Impact of choice of inhalers for asthma care on global carbon footprint and societal costs: a long-term economic evaluation |
| biblio.issue | 1 |
| biblio.volume | 25 |
| biblio.last_page | 953 |
| biblio.first_page | 940 |
| topics[0].id | https://openalex.org/T11651 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9944999814033508 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Inhalation and Respiratory Drug Delivery |
| topics[1].id | https://openalex.org/T10190 |
| topics[1].field.id | https://openalex.org/fields/23 |
| topics[1].field.display_name | Environmental Science |
| topics[1].score | 0.9939000010490417 |
| topics[1].domain.id | https://openalex.org/domains/3 |
| topics[1].domain.display_name | Physical Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2307 |
| topics[1].subfield.display_name | Health, Toxicology and Mutagenesis |
| topics[1].display_name | Air Quality and Health Impacts |
| topics[2].id | https://openalex.org/T11244 |
| topics[2].field.id | https://openalex.org/fields/23 |
| topics[2].field.display_name | Environmental Science |
| topics[2].score | 0.9915000200271606 |
| topics[2].domain.id | https://openalex.org/domains/3 |
| topics[2].domain.display_name | Physical Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2307 |
| topics[2].subfield.display_name | Health, Toxicology and Mutagenesis |
| topics[2].display_name | Climate Change and Health Impacts |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.6835079789161682 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2780261241 |
| concepts[1].level | 3 |
| concepts[1].score | 0.669975757598877 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1394363 |
| concepts[1].display_name | Inhaler |
| concepts[2].id | https://openalex.org/C2780936489 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6498479843139648 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q310667 |
| concepts[2].display_name | Carbon footprint |
| concepts[3].id | https://openalex.org/C2776042228 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6350133419036865 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q35869 |
| concepts[3].display_name | Asthma |
| concepts[4].id | https://openalex.org/C47737302 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5863567590713501 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q167336 |
| concepts[4].display_name | Greenhouse gas |
| concepts[5].id | https://openalex.org/C127598652 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5658327341079712 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q558635 |
| concepts[5].display_name | Per capita |
| concepts[6].id | https://openalex.org/C99454951 |
| concepts[6].level | 1 |
| concepts[6].score | 0.4704270362854004 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[6].display_name | Environmental health |
| concepts[7].id | https://openalex.org/C2908647359 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4291646480560303 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[7].display_name | Population |
| concepts[8].id | https://openalex.org/C39432304 |
| concepts[8].level | 0 |
| concepts[8].score | 0.33350515365600586 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q188847 |
| concepts[8].display_name | Environmental science |
| concepts[9].id | https://openalex.org/C18903297 |
| concepts[9].level | 1 |
| concepts[9].score | 0.0 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7150 |
| concepts[9].display_name | Ecology |
| concepts[10].id | https://openalex.org/C126322002 |
| concepts[10].level | 1 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[10].display_name | Internal medicine |
| concepts[11].id | https://openalex.org/C86803240 |
| concepts[11].level | 0 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[11].display_name | Biology |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.6835079789161682 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/inhaler |
| keywords[1].score | 0.669975757598877 |
| keywords[1].display_name | Inhaler |
| keywords[2].id | https://openalex.org/keywords/carbon-footprint |
| keywords[2].score | 0.6498479843139648 |
| keywords[2].display_name | Carbon footprint |
| keywords[3].id | https://openalex.org/keywords/asthma |
| keywords[3].score | 0.6350133419036865 |
| keywords[3].display_name | Asthma |
| keywords[4].id | https://openalex.org/keywords/greenhouse-gas |
| keywords[4].score | 0.5863567590713501 |
| keywords[4].display_name | Greenhouse gas |
| keywords[5].id | https://openalex.org/keywords/per-capita |
| keywords[5].score | 0.5658327341079712 |
| keywords[5].display_name | Per capita |
| keywords[6].id | https://openalex.org/keywords/environmental-health |
| keywords[6].score | 0.4704270362854004 |
| keywords[6].display_name | Environmental health |
| keywords[7].id | https://openalex.org/keywords/population |
| keywords[7].score | 0.4291646480560303 |
| keywords[7].display_name | Population |
| keywords[8].id | https://openalex.org/keywords/environmental-science |
| keywords[8].score | 0.33350515365600586 |
| keywords[8].display_name | Environmental science |
| language | en |
| locations[0].id | doi:10.1080/13696998.2022.2088196 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S155267287 |
| locations[0].source.issn | 1369-6998, 1941-837X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1369-6998 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Journal of Medical Economics |
| locations[0].source.host_organization | https://openalex.org/P4310320449 |
| locations[0].source.host_organization_name | Informa |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320449 |
| locations[0].source.host_organization_lineage_names | Informa |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Medical Economics |
| locations[0].landing_page_url | https://doi.org/10.1080/13696998.2022.2088196 |
| locations[1].id | pmid:35686860 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Journal of medical economics |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/35686860 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5054293969 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8008-4691 |
| authorships[0].author.display_name | Kalé Kponee-Shovein |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I79463011 |
| authorships[0].affiliations[0].raw_affiliation_string | Analysis Group, Inc., Boston, MA, USA |
| authorships[0].institutions[0].id | https://openalex.org/I79463011 |
| authorships[0].institutions[0].ror | https://ror.org/044jp1563 |
| authorships[0].institutions[0].type | company |
| authorships[0].institutions[0].lineage | https://openalex.org/I79463011 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Analysis Group (United States) |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Kalé Kponee-Shovein |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Analysis Group, Inc., Boston, MA, USA |
| authorships[1].author.id | https://openalex.org/A5012568692 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-0757-5865 |
| authorships[1].author.display_name | Jessica Marvel |
| authorships[1].countries | CH |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I1283582996 |
| authorships[1].affiliations[0].raw_affiliation_string | Novartis Pharma AG, Basel, Switzerland |
| authorships[1].institutions[0].id | https://openalex.org/I1283582996 |
| authorships[1].institutions[0].ror | https://ror.org/02f9zrr09 |
| authorships[1].institutions[0].type | company |
| authorships[1].institutions[0].lineage | https://openalex.org/I1283582996 |
| authorships[1].institutions[0].country_code | CH |
| authorships[1].institutions[0].display_name | Novartis (Switzerland) |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Jessica Marvel |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Novartis Pharma AG, Basel, Switzerland |
| authorships[2].author.id | https://openalex.org/A5061152610 |
| authorships[2].author.orcid | https://orcid.org/0009-0007-9877-9137 |
| authorships[2].author.display_name | Ryotaro Ishikawa |
| authorships[2].countries | CH |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1283582996 |
| authorships[2].affiliations[0].raw_affiliation_string | Novartis Pharma AG, Basel, Switzerland |
| authorships[2].institutions[0].id | https://openalex.org/I1283582996 |
| authorships[2].institutions[0].ror | https://ror.org/02f9zrr09 |
| authorships[2].institutions[0].type | company |
| authorships[2].institutions[0].lineage | https://openalex.org/I1283582996 |
| authorships[2].institutions[0].country_code | CH |
| authorships[2].institutions[0].display_name | Novartis (Switzerland) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Ryotaro Ishikawa |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Novartis Pharma AG, Basel, Switzerland |
| authorships[3].author.id | https://openalex.org/A5056536569 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Abhay Choubey |
| authorships[3].countries | IN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210090302 |
| authorships[3].affiliations[0].raw_affiliation_string | Novartis Healthcare Private Limited, Hyderabad, India |
| authorships[3].institutions[0].id | https://openalex.org/I4210090302 |
| authorships[3].institutions[0].ror | https://ror.org/00dhvr506 |
| authorships[3].institutions[0].type | company |
| authorships[3].institutions[0].lineage | https://openalex.org/I1283582996, https://openalex.org/I4210090302 |
| authorships[3].institutions[0].country_code | IN |
| authorships[3].institutions[0].display_name | Novartis (India) |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Abhay Choubey |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Novartis Healthcare Private Limited, Hyderabad, India |
| authorships[4].author.id | https://openalex.org/A5048205129 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-9107-363X |
| authorships[4].author.display_name | Harneet Kaur |
| authorships[4].countries | IN |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210090302 |
| authorships[4].affiliations[0].raw_affiliation_string | Novartis Healthcare Private Limited, Hyderabad, India |
| authorships[4].institutions[0].id | https://openalex.org/I4210090302 |
| authorships[4].institutions[0].ror | https://ror.org/00dhvr506 |
| authorships[4].institutions[0].type | company |
| authorships[4].institutions[0].lineage | https://openalex.org/I1283582996, https://openalex.org/I4210090302 |
| authorships[4].institutions[0].country_code | IN |
| authorships[4].institutions[0].display_name | Novartis (India) |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Harneet Kaur |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Novartis Healthcare Private Limited, Hyderabad, India |
| authorships[5].author.id | https://openalex.org/A5004587458 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-9222-5466 |
| authorships[5].author.display_name | Khadidja Ngom |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I79463011 |
| authorships[5].affiliations[0].raw_affiliation_string | Analysis Group, Inc., Boston, MA, USA |
| authorships[5].institutions[0].id | https://openalex.org/I79463011 |
| authorships[5].institutions[0].ror | https://ror.org/044jp1563 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I79463011 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Analysis Group (United States) |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Khadidja Ngom |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Analysis Group, Inc., Boston, MA, USA |
| authorships[6].author.id | https://openalex.org/A5088043345 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Iman Fakih |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I79463011 |
| authorships[6].affiliations[0].raw_affiliation_string | Analysis Group, Inc., Boston, MA, USA |
| authorships[6].institutions[0].id | https://openalex.org/I79463011 |
| authorships[6].institutions[0].ror | https://ror.org/044jp1563 |
| authorships[6].institutions[0].type | company |
| authorships[6].institutions[0].lineage | https://openalex.org/I79463011 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Analysis Group (United States) |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Iman Fakih |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Analysis Group, Inc., Boston, MA, USA |
| authorships[7].author.id | https://openalex.org/A5001581687 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Natalia Swartz |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I79463011 |
| authorships[7].affiliations[0].raw_affiliation_string | Analysis Group, Inc., Boston, MA, USA |
| authorships[7].institutions[0].id | https://openalex.org/I79463011 |
| authorships[7].institutions[0].ror | https://ror.org/044jp1563 |
| authorships[7].institutions[0].type | company |
| authorships[7].institutions[0].lineage | https://openalex.org/I79463011 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Analysis Group (United States) |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Natalia Swartz |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Analysis Group, Inc., Boston, MA, USA |
| authorships[8].author.id | https://openalex.org/A5009127579 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Todd Schatzki |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I79463011 |
| authorships[8].affiliations[0].raw_affiliation_string | Analysis Group, Inc., Boston, MA, USA |
| authorships[8].institutions[0].id | https://openalex.org/I79463011 |
| authorships[8].institutions[0].ror | https://ror.org/044jp1563 |
| authorships[8].institutions[0].type | company |
| authorships[8].institutions[0].lineage | https://openalex.org/I79463011 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Analysis Group (United States) |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Todd Schatzki |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Analysis Group, Inc., Boston, MA, USA |
| authorships[9].author.id | https://openalex.org/A5039428639 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-4067-8962 |
| authorships[9].author.display_name | James Signorovitch |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I79463011 |
| authorships[9].affiliations[0].raw_affiliation_string | Analysis Group, Inc., Boston, MA, USA |
| authorships[9].institutions[0].id | https://openalex.org/I79463011 |
| authorships[9].institutions[0].ror | https://ror.org/044jp1563 |
| authorships[9].institutions[0].type | company |
| authorships[9].institutions[0].lineage | https://openalex.org/I79463011 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Analysis Group (United States) |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | James Signorovitch |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Analysis Group, Inc., Boston, MA, USA |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1080/13696998.2022.2088196 |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Impact of choice of inhalers for asthma care on global carbon footprint and societal costs: a long-term economic evaluation |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11651 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9944999814033508 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Inhalation and Respiratory Drug Delivery |
| related_works | https://openalex.org/W3139171050, https://openalex.org/W4295812120, https://openalex.org/W2972473531, https://openalex.org/W2883050567, https://openalex.org/W2537228871, https://openalex.org/W4297499194, https://openalex.org/W2971760015, https://openalex.org/W2583539913, https://openalex.org/W4323035171, https://openalex.org/W3036815950 |
| cited_by_count | 27 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 12 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 12 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 3 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1080/13696998.2022.2088196 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S155267287 |
| best_oa_location.source.issn | 1369-6998, 1941-837X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1369-6998 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Journal of Medical Economics |
| best_oa_location.source.host_organization | https://openalex.org/P4310320449 |
| best_oa_location.source.host_organization_name | Informa |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320449 |
| best_oa_location.source.host_organization_lineage_names | Informa |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Medical Economics |
| best_oa_location.landing_page_url | https://doi.org/10.1080/13696998.2022.2088196 |
| primary_location.id | doi:10.1080/13696998.2022.2088196 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S155267287 |
| primary_location.source.issn | 1369-6998, 1941-837X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1369-6998 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Journal of Medical Economics |
| primary_location.source.host_organization | https://openalex.org/P4310320449 |
| primary_location.source.host_organization_name | Informa |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320449 |
| primary_location.source.host_organization_lineage_names | Informa |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Medical Economics |
| primary_location.landing_page_url | https://doi.org/10.1080/13696998.2022.2088196 |
| publication_date | 2022-06-10 |
| publication_year | 2022 |
| referenced_works | https://openalex.org/W2621906136, https://openalex.org/W2102583457, https://openalex.org/W2985861716, https://openalex.org/W2077722212, https://openalex.org/W6769588581, https://openalex.org/W2981264931, https://openalex.org/W3045514455, https://openalex.org/W4200296569, https://openalex.org/W2982475516, https://openalex.org/W2961428931, https://openalex.org/W1938708537, https://openalex.org/W3033759459, https://openalex.org/W2033134661, https://openalex.org/W2090085954, https://openalex.org/W2036637171, https://openalex.org/W4246469056, https://openalex.org/W2032417798, https://openalex.org/W1585978007, https://openalex.org/W2590363245, https://openalex.org/W1934151394, https://openalex.org/W1979448840, https://openalex.org/W3038237481, https://openalex.org/W3014530369, https://openalex.org/W2593081380, https://openalex.org/W4210839352, https://openalex.org/W2133893447, https://openalex.org/W2131648680, https://openalex.org/W2963056184, https://openalex.org/W3030154712 |
| referenced_works_count | 29 |
| abstract_inverted_index.by | 2 |
| abstract_inverted_index.in | 19, 22 |
| abstract_inverted_index.of | 40 |
| abstract_inverted_index.on | 33 |
| abstract_inverted_index.or | 28 |
| abstract_inverted_index.to | 7 |
| abstract_inverted_index.GHG | 23 |
| abstract_inverted_index.and | 4 |
| abstract_inverted_index.for | 14 |
| abstract_inverted_index.the | 34 |
| abstract_inverted_index.use | 39 |
| abstract_inverted_index.DPIs | 13 |
| abstract_inverted_index.MDIs | 11, 41 |
| abstract_inverted_index.SCC. | 35 |
| abstract_inverted_index.cost | 30 |
| abstract_inverted_index.that | 37 |
| abstract_inverted_index.with | 12, 25 |
| abstract_inverted_index.would | 17 |
| abstract_inverted_index.Global | 0 |
| abstract_inverted_index.asthma | 15 |
| abstract_inverted_index.costs, | 27 |
| abstract_inverted_index.global | 43 |
| abstract_inverted_index.result | 18 |
| abstract_inverted_index.control | 16 |
| abstract_inverted_index.efforts | 1 |
| abstract_inverted_index.warrant | 42 |
| abstract_inverted_index.Policies | 36 |
| abstract_inverted_index.decrease | 38 |
| abstract_inverted_index.savings, | 31 |
| abstract_inverted_index.available | 10 |
| abstract_inverted_index.currently | 9 |
| abstract_inverted_index.depending | 32 |
| abstract_inverted_index.emissions | 24 |
| abstract_inverted_index.potential | 29 |
| abstract_inverted_index.attention. | 44 |
| abstract_inverted_index.manageable | 26 |
| abstract_inverted_index.reductions | 21 |
| abstract_inverted_index.substitute | 8 |
| abstract_inverted_index.substantial | 20 |
| abstract_inverted_index.environmental | 3 |
| abstract_inverted_index.health-policy | 5 |
| abstract_inverted_index.decision-makers | 6 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 96 |
| corresponding_author_ids | https://openalex.org/A5054293969 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 10 |
| corresponding_institution_ids | https://openalex.org/I79463011 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/11 |
| sustainable_development_goals[0].score | 0.49000000953674316 |
| sustainable_development_goals[0].display_name | Sustainable cities and communities |
| citation_normalized_percentile.value | 0.95494743 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |